Anticoagulants-Competitive Landscape, & Pipeline Insights, 2015

Date: 2015-11

The Report, “Anticoagulants-Competitive Landscape, & Pipeline Insights, 2015” analyzes that Anticoagulants has lot of future scope and potential in the market. Mostly anticoagulants are being used in Venous Thromboembolism and Atrial Fibrillation. There are 16 anticoagulants in pipeline for venous thromboembolism, Atrial Fibrillation, Acute Coronary Syndrome, Stroke and Myocardial Infarction.The new report analysis predicts that global VTE therapeutics market was worth USD 4 billion in 2014 and expected to reach USD 5.5 billion by 2018 with a Compound Annual Growth Rate (CAGR) of 8.29%.The report analysis forecasts that global Atrial Fibrillation market will reach on its peak value USD 13.28 billion in 2018 from USD 7.86 billion in 2014 with compound annual growth rate (CAGR) of 14%.The Anticoagulants’ market is expected to decline after 2018 as many anticoagulants are going to be generic.

Please note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated mode of therapy.

Contact With Us
Join templatemonster at google+
Customized Research
Request Sample